|Application ||WB, FC, E|
|Calculated MW||29910 Da|
|Antigen Region||29-58 aa|
|Other Names||DnaJ homolog subfamily C member 9, DnaJ protein SB73, DNAJC9|
|Target/Specificity||This DNAJC9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 29-58 amino acids from the N-terminal region of human DNAJC9.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||DNAJC9 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||May play a role as co-chaperone of the Hsp70 family proteins HSPA1A, HSPA1B and HSPA8.|
|Cellular Location||Nucleus. Cytoplasm. Cell membrane. Note=Predominantly nuclear Translocates to the cytoplasm and membrane after heat shock|
|Tissue Location||Expressed in heart, placenta, liver, skeletal muscle, kidney, pancreas, thymus, ovary, colon and peripheral blood.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
DNAJC9 is upregulated at both mRNA and protein levels after various mitogenic and stress stimulations. DNAJC9 is mainly localized in cell nuclei under normal culture conditions, and transported into cytoplasm and plasma membrane upon heat shock stress through a non-classical and lipid-dependent pathway. DNAJC9 can interact with HSP70s and activate the ATPase activity of HSP70s, both of which are dependent on the J domain. Research has indicated that DNAJC9 is a novel cochaperone for HSP70s.
Rose, J. Phd, et al. Mol. Med. (2010) In press :
Pan, Z., et al. Neoplasma 57(2):123-128(2010)
Han, C., et al. Biochem. Biophys. Res. Commun. 353(2):280-285(2007)
Takamura, Y., et al. Biochem. Biophys. Res. Commun. 285(2):387-392(2001)
If you have any additional inquiries please email technical services at email@example.com.